TRPV4 and glaucoma: In fact, TRPV4 has been considered a potential therapeutic target to treat glaucoma because its inhibition has been found to improve the survival of RGCs (Taylor et al., 2017)Taken together, these studies highlight TRPV4 as a potential target in treating glaucoma.